Target- |
MechanismCell replacements |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell replacements |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Unknown statusPhase 1/2IIT Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
The aim of this study is to evaluate the safety and efficacy of iAPA-DC/CTL combined gemcitabine therapy on advanced pancreatic cancer.
100 Clinical Results associated with ImmunoGene Biotechology Co.,Ltd.
0 Patents (Medical) associated with ImmunoGene Biotechology Co.,Ltd.
100 Deals associated with ImmunoGene Biotechology Co.,Ltd.
100 Translational Medicine associated with ImmunoGene Biotechology Co.,Ltd.